Understanding Proton Pump Inhibitors (PPIs) and Their Risks

Welcome to our patient information page. This article provides general information about proton pump inhibitors (PPIs), their use in treating acid-related conditions, and potential risks associated with long-term use. It is not a substitute for professional medical advice. Always consult your doctor or pharmacist before starting or stopping any medication, and discuss any concerns about your health.

What Are Proton Pump Inhibitors (PPIs)?

Proton pump inhibitors (PPIs) are medications commonly prescribed to reduce stomach acid production, helping to manage conditions such as gastro-oesophageal reflux disease (GERD), heartburn, and peptic ulcers. They work by blocking the enzyme in the stomach lining responsible for producing acid, thereby relieving symptoms like heartburn, acid regurgitation, and abdominal pain. In Australia, PPIs are widely used and often have names ending in “-prazole,” reflecting their chemical class. Common examples available in Australia include:

• Omeprazole (e.g., Losec, Acimax)
• Esomeprazole (e.g., Nexium)
• Pantoprazole (e.g., Somac)
• Rabeprazole (e.g., Pariet)
• Lansoprazole (e.g., Zoton)

These medications are available as tablets or capsules, with some available over-the-counter in lower doses and others requiring a prescription. Your doctor will determine the most appropriate PPI and dosage for your condition.

Risks of Long-Term PPI Use

While PPIs are effective for managing acid-related conditions, prolonged use—often defined as more than a few months—can lead to potential health risks. These include:

• Nutrient Deficiencies: Stomach acid is essential for absorbing nutrients like vitamin B12, magnesium, and calcium. Long-term PPI use may cause deficiencies, increasing the risk of osteoporosis (weak bones) or nerve problems.
• Kidney Disease: Studies have linked prolonged PPI use to an increased risk of chronic kidney disease, with some patients developing issues after years of use.
• Infections: Reduced stomach acid can allow harmful bacteria to thrive, raising the risk of infections like pneumonia or Clostridioides difficile (C. diff), a serious gut infection.
• Heart Health: Some research suggests a slight increase in the risk of heart attacks or strokes with long-term PPI use, possibly due to changes in blood vessel function or low magnesium levels.
• Dementia: There is some concern about a potential link to dementia, but the evidence is inconclusive, and further research is needed.

These risks highlight the importance of using PPIs only when necessary and under medical supervision. Your doctor may recommend the lowest effective dose for the shortest possible time.

Misuse of PPIs for Gallstone Pain

A significant issue is the inappropriate use of PPIs to treat indigestion-like symptoms that may actually be caused by undiagnosed gallstones. Gallstones are hardened deposits in the gallbladder that can cause pain, nausea, or indigestion, especially after eating fatty foods. These symptoms can mimic acid reflux or heartburn, leading to the mistaken use of PPIs like omeprazole or esomeprazole. However, PPIs do not treat gallstone-related issues, and misdiagnosis can delay appropriate treatment, such as surgery or lifestyle changes, potentially leading to complications like gallbladder inflammation or infection. If you are taking a PPI for persistent indigestion and symptoms do not improve, consult your doctor to investigate other causes, such as gallstones.

Stopping PPIs Safely

If you have been using PPIs (e.g., pantoprazole or rabeprazole) for an extended period, do not stop them abruptly. Sudden discontinuation can cause rebound acid hypersecretion, where the stomach produces excessive acid, leading to worsened heartburn or discomfort. Instead, work with your doctor to gradually taper the dose while exploring alternatives, such as:

• Lifestyle Changes: Avoiding trigger foods (e.g., spicy or fatty foods), maintaining a healthy weight, and elevating the head of your bed during sleep.
• Other Medications: H2 receptor blockers (e.g., ranitidine, famotidine) may be considered as an alternative to PPIs in some cases.

When to See a Doctor

Contact your doctor if you experience persistent heartburn, regurgitation, or indigestion that does not improve with PPIs, as this could indicate another condition like gallstones. For emergencies, such as severe abdominal pain, difficulty breathing, or vomiting blood, go to the nearest hospital or call triple zero (000) in Australia.

This information is based on general medical knowledge and is not intended to diagnose or treat any condition. For personalised advice, please consult a qualified healthcare professional.

References

• Vaezi, M. F., et al. (2017). Complications of Proton Pump Inhibitor Therapy. Gastroenterology, 153(1), 35–48.
• Freedberg, D. E., et al. (2017). The Risks and Benefits of Long-term Use of Proton Pump Inhibitors. Nature Reviews Gastroenterology & Hepatology, 14(7), 391–400.
• American Gastroenterological Association. (2020). Appropriate Use of Proton Pump Inhibitors. Clinical Guidelines.
• Australian Therapeutic Guidelines. (2023). Gastrointestinal guidelines: Management of gastro-oesophageal reflux disease. Therapeutic Guidelines Limited. Accessed via Therapeutic Guidelines database.
• Malfertheiner, P., et al. (2022). Management of acid-related disorders: Focus on proton pump inhibitors. Gut, 71(9), 1823–1835.

These references were selected for their recency and relevance as of 2025. For the latest updates, check reputable sources like PubMed or Australian health authorities.